Literature DB >> 19765856

Interferon-gamma-mediated pathways are induced in human CD34(+) haematopoietic stem cells.

Katharina Kurz1, Yordanka Gluhcheva, Elissaveta Zvetkova, Guenther Konwalinka, Dietmar Fuchs.   

Abstract

Pro-inflammatory cytokines like interferon-gamma (IFN-gamma) are considered to be important in the development of anaemia of chronic disease (ACD). Both, inhibitory and stimulatory activities of IFN-gamma on erythropoiesis have been observed in vitro earlier. IFN-gamma induces several biochemical pathways in human monocytes, among them neopterin formation by GTP-cyclohydrolase I (GTP-CH I) and tryptophan degradation by the enzyme indoleamine 2,3-dioxygenase (IDO). IDO-mediated tryptophan deprivation efficiently inhibits the growth of proliferating cells and microbes, thus we wanted to examine whether enhanced tryptophan degradation by monocytic precursor cells also suppresses erythropoiesis. Therefore, IFN-gamma-mediated pathways were investigated in human CD34(+) progenitor cells, and effects of IFN-gamma on the proliferative activity of different progenitor subpopulations were studied. Cells were either cultivated in agar-conditioned medium (ACM) or in medium containing erythroid growth factors interleukin-3 (IL-3) and stem cell factor (SCF; EGFCM). Stimulation of CD34(+) cells with IFN-gamma in different doses (either 5000U/ml once or 200 and 400U/ml every other day) induced tryptophan degradation and in parallel also neopterin formation. Unstimulated cells cultured with ACM produced higher amounts of neopterin and kynurenine (all p<0.05). IFN-gamma stimulated higher kynurenine and neopterin formation in cells cultivated in EGFCM, stimulation with 400U IFN-gamma every other day was most effective. IFN-gamma stimulated the growth and proliferation of CFU-E and BFU-E (3-8) in both media. In conclusion, stimulation of haematopoietic stem cells with IFN-gamma activates IDO and neopterin formation, and it also exerts an influence on the proliferation of various stem cell populations. Copyright 2009 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765856     DOI: 10.1016/j.imbio.2009.08.007

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  7 in total

1.  Isocitrate ameliorates anemia by suppressing the erythroid iron restriction response.

Authors:  Chanté L Richardson; Lorrie L Delehanty; Grant C Bullock; Claudia M Rival; Kenneth S Tung; Donald L Kimpel; Sara Gardenghi; Stefano Rivella; Adam N Goldfarb
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

2.  Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors.

Authors:  Stefanie Andrea Erika Held; Annkristin Heine; Anne Ruth Kesper; Kathrin Schönberg; Anika Beckers; Dominik Wolf; Peter Brossart
Journal:  Oncoimmunology       Date:  2015-07-01       Impact factor: 8.110

3.  HemaMax™, a recombinant human interleukin-12, is a potent mitigator of acute radiation injury in mice and non-human primates.

Authors:  Lena A Basile; Dolph Ellefson; Zoya Gluzman-Poltorak; Katiana Junes-Gill; Vernon Mar; Sarita Mendonca; Joseph D Miller; Jamie Tom; Alice Trinh; Timothy K Gallaher
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

4.  Cytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-γ.

Authors:  Christian Schürch; Carsten Riether; Michael A Amrein; Adrian F Ochsenbein
Journal:  J Exp Med       Date:  2013-02-11       Impact factor: 14.307

Review 5.  Strategies to improve the immunosuppressive properties of human mesenchymal stem cells.

Authors:  Myoung Woo Lee; Somi Ryu; Dae Seong Kim; Ki Woong Sung; Hong Hoe Koo; Keon Hee Yoo
Journal:  Stem Cell Res Ther       Date:  2015-10-07       Impact factor: 6.832

Review 6.  The kynurenine pathway in stem cell biology.

Authors:  Simon P Jones; Gilles J Guillemin; Bruce J Brew
Journal:  Int J Tryptophan Res       Date:  2013-09-15

7.  GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer.

Authors:  Jin-Li Wei; Si-Yu Wu; Yun-Song Yang; Yi Xiao; Xi Jin; Xiao-En Xu; Xin Hu; Da-Qiang Li; Yi-Zhou Jiang; Zhi-Ming Shao
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.